drugset / Trial / NCT03150160
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to determine the incremental intraocular pressure (IOP) lowering that is achieved when Simbrinza is used adjunctively to Travatan in patients with normal tension glaucoma that may benefit from further IOP lowering.
Timeline
- Start
- 2017-09-21
- Primary completion
- 2017-12-04
- Completion
- 2017-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 0.2 % | Topical |
| Subject | Brinzolamide | Small molecule | 1 % | Topical |
| Background | Travoprost | Other / unclassified | 0.004 % | Topical |